Literature DB >> 26863230

Correction: First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent.

Joshua E Allen, Roslyn N Crowder, Wafik S El-Deiry.   

Abstract

Entities:  

Year:  2016        PMID： 26863230      PMCID： PMC4749207          DOI： 10.1371/journal.pone.0149365

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The second author’s name appears incorrectly. The correct name is Roslyn N. Crowder. The correct citation is: Allen JE, Crowder RN, El-Deiry WS (2015) First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent. PLoS ONE 10(11): e0143082. doi:10.1371/journal.pone.0143082
  1 in total

1.  First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent.

Authors:  Joshua E Allen; Roslyn N Crowder; Roslyn Crowder; Wafik S El-Deiry
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240
  1 in total
  1 in total

1.  Combined Drug Targeting of p53-dependent and -independent Pathways Depletes Myelofibrosis Hematopoietic Stem/Progenitor Cells.

Authors:  Min Lu; Lijuan Xia; Nada Elmansy; Cara Clementelli; Douglas Tremblay; Ronald Hoffman
Journal:  Leukemia       Date:  2021-10-12       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.